-
|
Benzinga –
12:14 PM ET 05/13/2022
On Friday, 153 companies set new 52-week lows. On Friday, the following stocks hit new 52-week lows: Be sure to monitor Benzinga for the news traders need!
|
-
|
Reuters –
8:23 AM ET 05/05/2022
Xtant Medical Holdings Inc (XTNT): * XTANT MEDICAL ANNOUNCES FIRST QUARTER 2022 FINANCIAL RESULTS. * Q1 LOSS PER SHARE $0.03. * Q1 REVENUE $13 MILLION VERSUS $12.5 MILLION Source text for Eikon: Further company coverage:
|
-
|
GlobeNewswire –
8:00 AM ET 05/05/2022
Xtant Medical Holdings, Inc. (XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2022.
|
-
|
Benzinga –
4:43 AM ET 05/05/2022
** Mirum Pharmaceuticals is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million. ** Bluegreen Vacations is estimated to report quarterly earnings at $0.53 per share on revenue of $181.17 million. ** Selecta Biosciences is expected to report quarterly loss at $0.11 per share on revenue of $13.12 million.
|
-
|
Reuters –
9:34 AM ET 05/02/2022
Xtant Medical Holdings Inc (XTNT): * XTANT MEDICAL APPOINTS SCOTT NEILS AS CHIEF FINANCIAL OFFICER. * Xtant Medical Holdings Inc (XTNT) - ANNOUNCED APPOINTMENT OF SCOTT NEILS AS CHIEF FINANCIAL OFFICER, EFFECTIVE JUNE 1, 2022 Source text for Eikon: Further company coverage:
|
-
|
GlobeNewswire –
8:00 AM ET 05/02/2022
Xtant Medical Holdings, Inc. (XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Chief Financial Officer, effective June 1, 2022.
|
-
|
GlobeNewswire –
8:30 AM ET 04/28/2022
Xtant Medical Holdings, Inc. (XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2022, before the open of the financial markets on Thursday, May 5, 2022.
|
-
|
GlobeNewswire –
8:00 AM ET 03/15/2022
Xtant Medical Holdings, Inc. (XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, will present at the Canaccord Musculoskeletal Conference on Tuesday, March 22, 2022, at 2:00 p.m. Central Time in Chicago.
|
-
|
GlobeNewswire –
7:00 AM ET 03/08/2022
Xtant Medical Holdings, Inc. (XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended December 31, 2021.
|
-
|
GlobeNewswire –
8:30 AM ET 03/01/2022
Xtant Medical Holdings, Inc. (XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2021, before the open of the financial markets on Tuesday, March 8, 2022.
|
-
|
GlobeNewswire –
8:00 AM ET 01/04/2022
Xtant Medical Holdings, Inc. (XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022.
|
-
|
GlobeNewswire –
8:00 AM ET 01/03/2022
Xtant Medical Holdings, Inc. (XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Interim Chief Financial Officer succeeding Greg Jensen, the Companys current Vice President, Finance and Chief Financial Officer, effective January 3, 2022.
|
Page:
|
Today's and Upcoming Events
No events in the next 90 days
Past Events (last 90 days)
-
XTNT announced Q1 earnings.
Data provided by Thomson Reuters © 2022
|